These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 22354300

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.
    Hengzhuang W, Wu H, Ciofu O, Song Z, Høiby N.
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4469-74. PubMed ID: 21670181
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF, Powell LC, Jack AA, Powell K, Beck K, Florance H, Forton J, Rye PD, Dessen A, Hill KE, Thomas DW.
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [Abstract] [Full Text] [Related]

  • 6. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
    Hengzhuang W, Green K, Pressler T, Skov M, Katzenstein TL, Wu X, Høiby N.
    Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159
    [Abstract] [Full Text] [Related]

  • 7. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing Pseudomonas aeruginosa.
    Müsken M, Pawar V, Schwebs T, Bähre H, Felgner S, Weiss S, Häussler S.
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
    [Abstract] [Full Text] [Related]

  • 8. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.
    Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J, Nation RL.
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1117-24. PubMed ID: 20028824
    [Abstract] [Full Text] [Related]

  • 9. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT, Sun SP, Chan JG, Wang P, Barraud N, Rice SA, Wang J, Li J, Chan HK.
    Mol Pharm; 2015 Aug 03; 12(8):2594-603. PubMed ID: 25423590
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm.
    Benavent E, Ulldemolins M, El Haj C, Rigo-Bonnin R, Yu H, Wang L, Wickremasinghe H, Ariza J, Murillo O.
    Int J Antimicrob Agents; 2023 Aug 03; 62(2):106856. PubMed ID: 37211260
    [Abstract] [Full Text] [Related]

  • 11. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients.
    Sans-Serramitjana E, Fusté E, Martínez-Garriga B, Merlos A, Pastor M, Pedraz JL, Esquisabel A, Bachiller D, Vinuesa T, Viñas M.
    J Cyst Fibros; 2016 Sep 03; 15(5):611-8. PubMed ID: 26708265
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo.
    Hengzhuang W, Høiby N, Ciofu O.
    Methods Mol Biol; 2014 Sep 03; 1147():239-54. PubMed ID: 24664838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
    Kolpen M, Appeldorff CF, Brandt S, Mousavi N, Kragh KN, Aydogan S, Uppal HA, Bjarnsholt T, Ciofu O, Høiby N, Jensen PØ.
    Pathog Dis; 2016 Feb 03; 74(1):ftv086. PubMed ID: 26458402
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct 03; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 19. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J, Murillo O, Bergen PJ, Nation RL, Poudyal A, Luo X, Yu HY, Ariza J, Li J.
    J Antimicrob Chemother; 2014 Sep 03; 69(9):2434-42. PubMed ID: 24833752
    [Abstract] [Full Text] [Related]

  • 20. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.
    Harrison JJ, Turner RJ, Ceri H.
    Environ Microbiol; 2005 Jul 03; 7(7):981-94. PubMed ID: 15946294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.